There was high concordance between RLTPR (AUC: 0.71, 95%CI: 0.59-0.83), SLFN13(AUC: 0.78, 95%CI: 0.67-0.89), MIR4500HG (AUC: 0.74, 95%CI: 0.62-0.85), HYDIN (AUC: 0.72, 95%CI: 0.61-0.83) and TPRG1 (AUC: 0.75, 95%CI: 0.64-0.86) abnormal expressions and tumor early recurrence (Figure 4F). This evidence concerns the gene SLFN13 and neoplasm.